ChengDa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
ChengDa Pharmaceuticals has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥162.4M respectively. ChengDa Pharmaceuticals's EBIT is CN¥37.0M making its interest coverage ratio -0.9. It has cash and short-term investments of CN¥1.2B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -0.9x |
| Cash | CN¥1.18b |
| Equity | CN¥2.23b |
| Total liabilities | CN¥162.38m |
| Total assets | CN¥2.40b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301201's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥157.7M).
Long Term Liabilities: 301201's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥4.6M).
Debt to Equity History and Analysis
Debt Level: 301201 is debt free.
Reducing Debt: 301201 has no debt compared to 5 years ago when its debt to equity ratio was 35.7%.
Debt Coverage: 301201 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301201 has no debt, therefore coverage of interest payments is not a concern.